4.5 Article

Association of Hepatic Steatosis Index and Fatty Liver Index with Carotid Atherosclerosis in 2 Diabetes

Journal

INTERNATIONAL JOURNAL OF MEDICAL SCIENCES
Volume 18, Issue 14, Pages 3280-3289

Publisher

IVYSPRING INT PUBL
DOI: 10.7150/ijms.62010

Keywords

Hepatic steatosis index; Fatty liver index; Type 2 diabetes; Carotid atherosclerosis; Macrovascular complication

Funding

  1. National Natural Science Foundation of China [81870548, 81570721]
  2. Social Development Project of Jiangsu Province [BE2018692]
  3. Natural Science Foundation of Jiangsu Province, China [BK20191222]
  4. Scientific Research Projects of Jiangsu Health and Family Planning Commission [Y2018109]
  5. High Caliber Medical Personnel Foundation of Jiangsu Province [LGY2016053]
  6. Six Talent Peaks Project in Jiangsu Province [2015WSN006]
  7. Social Development Project of Zhenjiang City [SH2019041]
  8. Fifth 169 project Scientific Research Project of Zhenjiang City, Jiangsu Province

Ask authors/readers for more resources

The study found that HSI and FLI are independently correlated with carotid atherosclerosis in patients with type 2 diabetes mellitus. Increasing values of HSI and FLI were significantly associated with CIMT across different age and hypertension categories. These indices may serve as simple and useful markers for evaluating the progression of diabetic macrovascular complications.
Background/aim: Previous studies have suggested that the hepatic steatosis index (HSI) and fatty liver index (FLI) can be used as a predictor of non-alcoholic fatty liver disease (NAFLD). The aim of our study was to determine whether non-invasive indices of hepatic steatosis (HSI and FLI) are associated with carotid atherosclerosis in type 2 diabetes mellitus (T2DM). Methods: This was a cross-sectional study conducted in the T2DM patients (n=768). Carotid intima-media thickness (CIMT) was measured by the Color Doppler ultrasound. The HSI was calculated based on gender, body mass index (BMI), and transaminases level. The FLI was based on BMI, waist circumference (WC), triacylglycerols (TG) and g-glutamyl transferase (GGT). Results: Raised HSI and FLI levels was associated with increased CIMT levels in T2DM patients. Patients with greater CIMT had higher HSI (39.10 +/- 5.70 vs 36.10 +/- 4.18, P < 0.001) and FLI (46.35 (29.96, 65.54) vs 36.93 (18.7, 57.93), P < 0.001) than those with lower CIMT. Subjects with existing carotid plaque had higher HSI (38.28 +/- 5.63 vs 35.69 +/- 3.45 P < 0.001) and FLI (47.41 (27.77, 66.62) vs 37.19 (17.71, 51.78), P < 0.001) accordingly. HSI (r = 0.343, P < 0.001) and FLI (r = 0.184, P < 0.001) were positively related with the CIMT. In the linear regression, after full adjustment metabolic risk factors, smoking, and measures of insulin resistance, HSI and FLI were independently associated with CIMT (HSI: beta = 0.011, FLI: beta = 0.001, all P < 0.01). Further, logistic regression analyses showed that higher HSI and FLI had an impact on the risk for carotid atherosclerosis [HSI: OR (95%CI): 1.174 (1.123-1.228), FLI: OR (95%CI): 1.011(1.004-1.019), all P < 0.01]. Overall, increasing values of HSI and FLI were associated with CIMT (P < 0.05) significantly across different categories of age and hypertension. Conclusion: Current data suggest HSI and FLI are independently correlated with carotid atherosclerosis in T2DM. They may be a simple and useful marker for assessing the progression of diabetic macrovascular complications.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available